Johnson & Johnson (NYSE: JNJ) has kicked off construction on a $2 billion biologics manufacturing facility in Eastern North ...
After Trump threatened 25% tariffs on pharma imports, J&J became the latest pharma company to announce investments in the U.S.
4d
Daily Voice on MSNPharma Giant Cutting 400+ More East Hanover Jobs Ahead Of Major Drug Patent's ExpirationPharmaceutical company Novartis is laying off more than 400 employees at its East Hanover facility as part of a restructuring ...
The pharmaceutical company said the investment in the research-and-development center in Beijing will bolster its footprint ...
Bristol-Myers Squibb acquires 2seventy bio for $286M, marking the end of a once-promising biotech. Check out if this is a ...
However, through it all, Bourla steered the pharma giant to earnings that beat Wall Street estimates, warded off a continued fight with Starboard Value — which did not put forward any nominations ...
Authorities confirm an arson investigation in Madison. Global pharma giant Bayer confirms "an incident" at one of their ...
2d
MiBolsilloColombia on MSNPurdue Pharma's will pay compensation for bankruptcyPurdue Pharma, the pharmaceutical giant behind one of America's most popular painkillers, has taken a significant step by ...
2d
The Print on MSNFat-busting drug Mounjaro launched in India. Here’s how much it will costUS pharma giant Eli Lilly's Mounjaro can prove crucial in treatment of obesity & type 2 diabetes. Launched in the US in 2022, ...
Johnson & Johnson has laid out plans to raise U.S. investments by 25% to more than $55 billion over the next four years, as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results